DYN FY 2014 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.5B+48766.7% YoY

Gross Profit

$321M21.9% margin

Operating Income

-$318M-21.7% margin

Net Income

-$67M-4.6% margin

EPS (Diluted)

$-0.53

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$62M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.2B

Total Liabilities

$8.2B

Stockholders' Equity

$3.0B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$3M	+48766.7%
Gross Profit	$321M	-$1.1B	+128.1%
Operating Income	-$318M	-$318M	+0.0%
Net Income	-$67M	-$356M	+81.2%